FEATURED ARTICLES

• Using dSEC-7 Column For Separation And Length Determination Of mRNA

  mRNA analysis depends on methods that can separate broad size ranges. Learn how retention time can help estimate transcript length and complement capillary electrophoresis workflows.

• What Is Size Exclusion Chromatography (SEC)?

  Aggregation can compromise mAb quality at many stages of development. Learn why size exclusion chromatography is a trusted approach for detecting aggregates and supporting confident characterization.

• Peptide Mapping Of Adeno Associated Virus Capsid Proteins

  Peptide mapping helps reveal AAV capsid protein identity, sequence coverage, and potential modification patterns, giving gene therapy teams a clearer view of viral protein quality across workflows.

• Native RPLC For ADCs: How Column Hydrophobicity Shapes DAR Separation

  ADC characterization does not have to be overwhelmed by complex intact MS profiles. Smart column selection can improve separation, clarify critical quality attributes, and make ADC analysis easier.

• Sample Clean-Up After N-Linked Glycan Release And Labeling

  Glycan profiling starts with effective clean-up. See how comparable recovery across key labeled glycans and sialylated glycan groups can support confident analysis while helping labs manage costs.

• What Is Drug Antibody Ratio (DAR) And How It Relates To Biotherapeutics?

  DAR is a key quality attribute that shapes ADC potency, safety, stability, and developability. Learn why accurate measurement and control are essential as ADC pipelines expand and expectations rise.

• HPLC Method Development For Monoclonal Antibody Aggregates With SEC

  SEC for monoclonal antibodies is not always as simple as choosing a column and running PBS. Secondary interactions can affect recovery, making thoughtful method development essential.

• Protein Purification By HPLC: Methods, Benefits, And Best Practices

  Read about how HPLC protein purification enables precise, reproducible isolation of target proteins from complex mixtures while preserving structure and activity—supporting high-purity workflows.

• Exploring Protein Purification Methods: Essential Techniques

  Effective protein purification starts with matching the method to the molecule and the application. Learn how scale, throughput, purity goals, and empirical optimization influence successful recovery.

• Effects Of Sequence Fidelity On Cloning Efficiency

  dsDNA fragments speed up cloning but introduce variability that can affect results. Comparing fragment fidelity, efficiency, and design considerations helps researchers choose the right approach.

• An Accelerated Protein Engineering Workflow Utilizing Linear DNA

  Cell-free expression using linear DNA enables rapid protein production without cloning. See how strategic template design improves yield, supporting faster iteration and high-throughput screening.

• Maintain Control Of Pharmaceutical Water Systems

  Early TOC excursions often reveal hidden risks in water systems. Capturing samples at the moment of deviation helps teams confirm root causes faster, reduce uncertainty, and maintain control.

• Evaluating Carryover When Using A TOC Analyzer

  Accurate TOC results shouldn’t depend on sample order. See how low-level measurements remain reliable even after high-TOC analysis, helping reduce false positives and streamline decisions.

• AI Agents: The Scientists' New Allies

  AI agents are reshaping biopharma research, offering new ways to analyze data. Find out how success depends on strong data foundations, governance, and thoughtful adoption strategies.

• Advancing An Integrated Biopharma Workflow Strategy

  Global research teams were generating critical data in disconnected systems, hindering collaboration. Explore how unified workflows and a shared data backbone strengthen efficiency.

• How Can Data Translation Challenges In CRO Partnerships Be Overcome?

  Biopharma–CRO partnerships often struggle with fragmented communication. Gain insight into how streamlined, automated workflows improve transparency, data quality, and operational speed.

• Precision Medicine In IMIDs - The Path To Improved Healthcare Outcomes

  Precision medicine is opening new possibilities for IMIDs by moving beyond symptom‑based care. Find out how emerging multi‑omics tools are reshaping how these complex diseases are understood.

• Enhancing Biopharma ROI With In-House Long-Read Sequencing

  Long-read sequencing is redefining research by enabling clearer insights into complex genetic regions. Learn how this technology strengthens data confidence and accelerates modern R&D workflows.

• NGS Revolution For Cell And Gene Therapy Products

  Discover how next-generation sequencing offers a more efficient path to evaluating the critical quality attributes of cell and gene therapies while reducing assay complexity and accelerating progress.

• Enhancing Novel Developability Through Automated MS Analytics

  Growing biotherapeutic complexity demands MS workflows that can unify diverse datasets. Learn how automated approaches enhance data quality, streamline analysis, and support faster development.